OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic targeting of chromatin: status and opportunities
Marton I. Siklos, Stefan Kubicek
FEBS Journal (2021) Vol. 289, Iss. 5, pp. 1276-1301
Open Access | Times Cited: 16

Showing 16 citing articles:

Chromatin and Cancer: Implications of Disrupted Chromatin Organization in Tumorigenesis and Its Diversification
Poonam Sehgal, Pankaj Chaturvedi
Cancers (2023) Vol. 15, Iss. 2, pp. 466-466
Open Access | Times Cited: 12

Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors
J.R. Horton, Sarath Pathuri, Kristen Wong, et al.
Structure (2022) Vol. 30, Iss. 6, pp. 793-802.e5
Open Access | Times Cited: 21

TDP-43 Epigenetic Facets and Their Neurodegenerative Implications
Juliette Gimenez, Alida Spalloni, Sara Cappelli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13807-13807
Open Access | Times Cited: 9

Cosmic Ionizing Radiation: A DNA Damaging Agent That May Underly Excess Cancer in Flight Crews
Sneh M. Toprani, Christopher Scheibler, Irina Mordukhovich, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7670-7670
Open Access | Times Cited: 2

Cancer epigenetics: promises and pitfalls for cancer therapy
Eleni Skourti, Paraminder Dhillon
FEBS Journal (2022) Vol. 289, Iss. 5, pp. 1156-1159
Closed Access | Times Cited: 13

Tributyrin Mitigates Ethanol-Induced Lysine Acetylation of Histone-H3 and p65-NFκB Downregulating CCL2 Expression and Consequent Liver Inflammation and Injury
Smita Ghare, B Charpentier, Dushan T. Ghooray, et al.
Nutrients (2023) Vol. 15, Iss. 20, pp. 4397-4397
Open Access | Times Cited: 7

Novel Substituted Tetrazoles as ACSS2 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 12, pp. 1894-1895
Open Access | Times Cited: 10

Comparative Study of Adenosine Analogs as Inhibitors of Protein Arginine Methyltransferases and a Clostridioides difficile-Specific DNA Adenine Methyltransferase
Jujun Zhou, Youchao Deng, Iredia D. Iyamu, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 4, pp. 734-745
Open Access | Times Cited: 3

Novel Bromodomain BRD4 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 6, pp. 951-952
Open Access | Times Cited: 8

Amide-Substituted Condensed Pyridine Derivatives as ACSS2 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 12, pp. 1870-1871
Open Access | Times Cited: 8

Novel Bromodomain Inhibitors for Treating Cancer, Fibrosis, and Inflammatory Disorders
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 8, pp. 1200-1201
Open Access | Times Cited: 6

CDC20 Holds Novel Regulation Mechanism in RPA1 during Different Stages of DNA Damage to Induce Radio-Chemoresistance
Yang Gao, Pengbo Wen, Chenran Shao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8383-8383
Open Access

Staying in the loop blocks oncogene activation
Ilaria Iacobucci, Lindsey E. Montefiori
Blood (2024) Vol. 144, Iss. 22, pp. 2276-2277
Closed Access

The role of genes of the Argonaute family in the effects of the RNA interference activator enoxacin on the lifespan of Drosophila melanogaster
N. Pakshina, Daria V. Yakovleva, Natalia S. Ulyasheva, et al.
Proceedings of the Komi Science Centre of the Ural Division of the Russian Academy of Sciences (2023), Iss. 6, pp. 103-114
Open Access

DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro
Eliza Mari Kwesi‐Maliepaard, Muddassir Malik, Tibor van Welsem, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access

Page 1

Scroll to top